United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. important limitations of use: - qvar redihaler is not indicated for the relief of acute bronchospasm. qvar redihaler is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . qvar redihaler is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

United States - English - NLM (National Library of Medicine)

a-s medication solutions - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qvar redihaler is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. limitations of use: qvar redihaler is not indicated for the relief of acute bronchospasm.  qvar redihaler is contraindicated in: - the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - in patients with known hypersensitivity to beclomethasone dipropionate or any of the ingredients in qvar redihaler [see warnings and precautions (5.6)] . risk summary there are no adequate and well‑controlled studies with qvar redihaler or beclomethasone dipropionate in pregnant women. there are clinical considerations with the use of inhaled corticosteroids (ics), including beclomethasone dipropionate, in pregnant women [see clinical considerations] . also, no published studies, including studies of large birth registries, have to date related the use of ics to any increases

Malta - English - Medicines Authority

central procurement & supplies unit - beclometasone dipropionate - nasal spray, suspension - beclometasone dipropionate 50 µg - nasal preparations

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - beclometasone dipropionate - nasal spray, suspension - beclometasone dipropionate 50 µg - drugs for obstructive airway diseases

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - beclometasone dipropionate - spray - 50microgram/1dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - beclometasone dipropionate - spray - 50microgram/1dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - beclometasone dipropionate - spray - 50microgram/1dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - beclometasone dipropionate - spray - 50microgram/1dose